What's breaking now, across thousands of outlets.
Regeneron and Sanofi said they are in the early stages of discussing areas for further collaboration, building on one of the most fruitful pharmaceutical company partnerships in recent history. An expanded deal could include follow-on ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
A majority of FDA advisors backed Replimune’s advanced melanoma treatment, voting in favor of the product’s efficacy and the data produced in its study, marking a seismic victory for the company that…
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their companies? Find out on the latest episode of "The…
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn.
A team of paediatric doctors at Fiji's main hospital spent eight months seeking help from multiple other countries, including neighbours Australia and NZ, but only the Saudi's came through.
AI is the hottest thing in medical care right now — but many of us feel trepidation about it. Just one illustrative public survey sample: An October 2025 KFF poll found just 8 percent of Americans…
RIO DE JANEIRO – A graph showing the progression of HIV infections in Fiji resembles a cobra poised to strike. For years, the 330+ islands that make up Fiji had almost zero HIV cases, but the…
